BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7566848)

  • 1. Malignant mixed mesodermal tumors of the ovary.
    DiSilvestro PA; Gajewski WH; Ludwig ME; Kourea H; Sung J; Granai CO
    Obstet Gynecol; 1995 Nov; 86(5):780-2. PubMed ID: 7566848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
    Le T; Krepart GV; Lotocki RJ; Heywood MS
    Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant mixed mesodermal tumors of the ovary: a clinical analysis of 12 cases].
    Li H; Shi S; Zhang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):460-2. PubMed ID: 10920946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary malignant mesodermal ovarian sarcomas.
    Gari A; Souhami L; Arseneau J; Stanimir G
    Int J Gynecol Cancer; 2006; 16(1):106-9. PubMed ID: 16445619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.
    Crotzer DR; Wolf JK; Gano JB; Gershenson DM; Levenback C
    Gynecol Oncol; 2007 May; 105(2):399-403. PubMed ID: 17292457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mixed uterine mesodermal sarcoma in the population of southern Israel in the years 1996-1971--clinical and pathological characteristics].
    Ariad S; Rabinovitz A; Yanai-Inbar I; Piura B
    Harefuah; 1998 Jan; 134(2):93-6, 159. PubMed ID: 9517289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian malignant mixed mesodermal tumor with neuroectodermal differentiation: a multifaceted evaluation.
    Mott RT; Murphy BA; Geisinger KR
    Int J Gynecol Pathol; 2010 May; 29(3):234-8. PubMed ID: 20407321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous endometrial malignant mixed mesodermal tumor and ovarian serous adenocarcinoma.
    Krigman HR; Coogan AC; Marks JR
    Arch Pathol Lab Med; 1995 Jan; 119(1):99-103. PubMed ID: 7802567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of malignant mixed mesodermal tumor (MMMT) of the ovary: MR features before and after chemotherapy.
    Kaji Y; Sugimura K; Yamamoto N; Imaoka I; Sugihara M
    Radiat Med; 1999; 17(1):81-3. PubMed ID: 10378658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for malignant mixed Müllerian tumors of the ovary.
    Sit AS; Price FV; Kelley JL; Comerci JT; Kunschner AJ; Kanbour-Shakir A; Edwards RP
    Gynecol Oncol; 2000 Nov; 79(2):196-200. PubMed ID: 11063643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of malignant germ cell tumor of the ovary.
    Aziz MF
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():262-76. PubMed ID: 7661594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary ovarian malignant mixed mesodermal tumor: report of four cases.
    Ki EY; Park JS; Mun JB; Hur SY
    Eur J Gynaecol Oncol; 2014; 35(5):584-8. PubMed ID: 25423710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mixed mesodermal tumor in a young woman with polycystic ovary syndrome. A case report.
    Karabakhtsian R; Heller DS; Singhal P; Sama J
    J Reprod Med; 2002 Nov; 47(11):946-8. PubMed ID: 12497688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinosarcoma of the ovary: 19 years of prospective data from a single center.
    Brown E; Stewart M; Rye T; Al-Nafussi A; Williams AR; Bradburn M; Smyth J; Gabra H
    Cancer; 2004 May; 100(10):2148-53. PubMed ID: 15139057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mixed mesodermal tumors of the ovary: a clinicopathologic assessment of 12 cases.
    Barwick KW; LiVolsi VA
    Am J Surg Pathol; 1980 Feb; 4(1):37-42. PubMed ID: 6244746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in granulosa cell tumor of the ovary].
    Wu L; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):673-6. PubMed ID: 11218897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary.
    Geisler JP; Wiemann MC; Miller GA; Zhou Z; Geisler HE
    J Surg Oncol; 1995 May; 59(1):45-7. PubMed ID: 7745977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium.
    Marth C; Windbichler G; Petru E; Dirschlmayer W; Obermair A; Czerwenka K; Müller-Holzner E; Dapunt O
    Gynecol Oncol; 1997 Jan; 64(1):121-5. PubMed ID: 8995559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent choriocarcinoma and malignant mixed mesodermal tumor of the uterus.
    Nguyen CP; Levi AW; Montz FJ; Bristow RE
    Gynecol Oncol; 2000 Dec; 79(3):499-503. PubMed ID: 11104628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.